Dubininskaya str. 57, bld.1, 115054, Moscow, Russia
info@regapharm.com

+7(499)517-95-23

Main  >  Laws and regulations  >  On the Rules for the Registration and Expertise of Medicines for Medical Use

On the Rules for the Registration and Expertise of Medicines for Medical Use

Decision of the Council of the Eurasian Economic Commission dated 03.11.2016 N 78 (as amended on 20.10.2023)

"On the Rules for the Registration and Expertise of Medicines for Medical Use"

Publication source

The document has not been published in this form.

The original text of the document was published in the publication

Official website of the Eurasian Economic Union http://www.eaeunion.org/, 21.11.2016.

For information on the publication of documents that create this version, see the help for these documents.

 

Note to the document

The version comes into effect on 20.12.2023.

 

The amendments introduced by the Decision of the EEC Council dated 20.10.2023 N 114 (as amended on 24.11.2023) entered into force on 20 December 2023.

 

Document title

Decision of the Council of the Eurasian Economic Commission dated 03.11.2016 N 78

(as amended on 20.10.2023)

"On the Rules for Registration and Expertise of Medicines for Medical Use"

 

COUNCIL OF THE EURASIAN ECONOMIC COMMISSION

 

DECISION

of November 3, 2016 N 78

 

ON THE RULES

OF REGISTRATION AND EXPERTISE OF MEDICINES

FOR MEDICAL USE

 

 

List of amending documents

(as amended by decisions of the Council of the Eurasian Economic Commission

dated 14.06.2018 N 55, dated 30.01.2020 N 9, dated 23.12.2020 N 128,

dated 05.03.2021 N 14, dated 23.04.2021 N 34, dated 17.03.2022 N 36,

dated 23.09.2022 N 141, dated 22.05.2023 N 60, dated 20.10.2023 N 114

 

In accordance with Article 7 of the Agreement on Uniform Principles and Rules for the Circulation of Medicines within the Eurasian Economic Union dated December 23, 2014, paragraph 84 of Appendix No. 1 to the Regulations of the Eurasian Economic Commission, approved by Decision of the Supreme Eurasian Economic Council dated December 23, 2014 No. 98, and Decision of the Supreme Eurasian Economic Council dated December 23, 2014 No. 108 "On the implementation of the Agreement on Uniform Principles and Rules for the Circulation of Medicines within the Eurasian Economic Union", the Council of the Eurasian Economic Commission decided:

 

  1. To approve the attached Rules for the Registration and Expertise of Medicines for Medical Use (hereinafter referred to as the Rules).

 

  1. Establish that:

 

a) registration, confirmation of registration (re-registration), amendments to the registration dossier and other procedures related to the registration of medicinal products for medical use, stipulated by the legislation of the Member States of the Eurasian Economic Union (hereinafter referred to as the Member States, the Union) and not completed by the authorized bodies of the Member States before January 1, 2016, shall be carried out in accordance with the legislation of the Member States;

 

b) until July 1, 2021 (in the Russian Federation - until December 31, 2020), at the applicant's discretion, registration of a medicinal product may be carried out either in accordance with the Rules or in accordance with the legislation of a Member State. In this case, medicinal products registered in accordance with the legislation of a Member State are allowed to circulate only in the territory of the Member State whose authorized body issued the registration certificate;

(as amended by the decision of the Council of the Eurasian Economic Commission dated 23.12.2020 N 128)

 

c) the validity of registration certificates of medicinal products submitted for registration (expert work for the purpose of registration) in accordance with the legislation of the Member States before July 1, 2021, may be extended in accordance with the legislation of the Member States, but not later than until December 31, 2025. At the same time, changes to the registration dossiers of such medicinal products, formed in accordance with the legislation of the Member States, are carried out in accordance with the legislation of the Member States no later than December 31, 2025;

(as amended by decisions of the Council of the Eurasian Economic Commission of 23.12.2020 N 128, of 05.03.2021 N 14)

 

d) medicinal products registered in accordance with the legislation of the Member States must be brought into compliance with the requirements of international treaties and acts constituting the law of the Union by December 31, 2025;

 

e) registration certificates of medicinal products issued in accordance with the legislation of the Member States are valid until their expiration date, but not later than December 31, 2025.

 

3. Member States, by December 31, 2016:

 

 

a) approve the amount of fees (duties) or other mandatory payments provided for by the Rules, taking into account the complexity of the procedures and the volume of work performed in the reference state and the states of recognition, including during:

 

registration of a medicinal product;

 

confirmation of registration (re-registration) of a medicinal product;

 

bringing the registration dossier of a medicinal product into line with the requirements of international treaties and acts constituting the law of the Union;

 

b) determine the bodies (organizations) authorized to carry out registration, confirmation of registration (re-registration), amendments to the registration dossier and other procedures related to the registration of medicinal products for medical use provided for by the Rules, and inform the Eurasian Economic Commission thereof.

 

4. This Decision shall enter into force after 10 calendar days from the date of entry into force of the Protocol signed on December 2, 2015, on the accession of the Republic of Armenia to the Agreement on uniform principles and rules for the circulation of medicines within the Eurasian Economic Union dated December 23, 2014, but not earlier than after 10 calendar days from the date of official publication of this Decision.

 

Members of the Council of the Eurasian Economic Commission:

 

From the Republic of Armenia

V. GABRIELYAN From the Republic of Belarus

V. MATYUSHEVSKY From the Republic of Kazakhstan

A. MAMIN From the Kyrgyz Republic

O. PANKRATOV From the Russian Federation

I. SHUVALOV

 

Approved by the Decision of the Council

 of the Eurasian Economic Commission

dated November 3, 2016 N 78

 

RULES FOR REGISTRATION AND EXPERTISE OF MEDICINES FOR MEDICAL USE

 

List of amending documents

(as amended by decisions of the Council of the Eurasian Economic Commission

dated 14.06.2018 N 55, dated 30.01.2020 N 9, dated 05.03.2021 N 14,

dated 23.04.2021 N 34, dated 17.03.2022 N 36, dated 23.09.2022 N 141,

dated 22.05.2023 N 60, dated 20.10.2023 N 114

 

 

I. General Provisions

 

1. These Rules determine the procedure for registration, confirmation of registration (re-registration), amendments to the registration dossier and examination of medicinal products for medical use in order to form a common market for medicinal products within the Eurasian Economic Union (hereinafter referred to as the Union), as well as other procedures related to the registration of medicinal products for medical use (hereinafter referred to as registration-related procedures), including:

 

a) bringing the registration dossier of a medicinal product registered under the national procedure in the Member States of the Union (hereinafter referred to as the Member States) into compliance with these Rules (hereinafter referred to as bringing into compliance with the requirements of the Union);

(subparagraph "a" as amended by Decision of the Council of the Eurasian Economic Commission dated 20.10.2023 N 114)

 

b) suspension and cancellation of registration of medicinal products or restriction of the use of a medicinal product;

 

c) issuance of duplicates of the registration certificate of a medicinal product.

 

2. The requirements of these Rules shall apply to developers and manufacturers of medicinal products, holders of registration certificates for medicinal products, their authorized representatives, and authorized bodies (expert organizations) of the Member States in the field of circulation of medicinal products.

 

3. The requirements of these Rules shall not apply to:

 

a) medicinal products that are intended for use in military operations, emergency situations, for the prevention and treatment of diseases and injuries resulting from exposure to chemical, biological, and radiation factors, developed on the instructions of state authorities of the Member States authorized in the field of security and defense, and the circulation of which is regulated by the legislation of the Member States;

 

a) medicinal products that are intended for use in emergency situations, the threat of their occurrence or the occurrence of emergency situations, for the prevention and treatment of diseases and injuries that pose a danger to others, resulting from exposure to chemical, biological, and radiation factors, the circulation of which is regulated by the legislation of the Member States;

(paragraph "a.1" introduced by the decision of the Council of the Eurasian Economic Commission dated 17.03.2022 N 36)

 

b) veterinary medicinal products, the circulation of which is regulated by other acts that are part of the law of the Union.

 

4. Medicinal products intended for circulation on the common market of medicinal products within the Union or on the territory of one of the Member States are subject to registration in accordance with these Rules.

 

5. The following are not subject to registration within the Union:

 

a) medicinal products manufactured in pharmacies;

 

b) pharmaceutical substances;

 

c) medicinal products intended for preclinical and clinical trials;

 

d) medicinal products imported by individuals for personal use;

 

e) radiopharmaceutical medicinal products manufactured directly in medical organizations in the manner established by the authorized bodies of the Member States;

(as amended by the Decision of the Council of the Eurasian Economic Commission of 17.03.2022 N 36)

 

f) medicinal products not intended for sale in the customs territory of the Union;

 

g) samples of medicinal products intended for registration and standard samples;

 

h) medicinal products intended for use as exhibition samples.

 

5.1. In the cases and in the manner stipulated by the legislation of the Member States, it is allowed to provide patients with and use them with unregistered medicinal products. Such medicinal products include, among other things:

medicines imported into a Member State to provide medical care for vital indications of a specific patient or to provide medical care to a limited group of patients with a rare and (or) particularly severe pathology, on the basis of a conclusion (permit document) issued by the authorized body of the Member State;

high-tech medicinal products manufactured on a non-standardized (non-routine) basis and used in the territory of the same Member State in a hospital for the purpose of fulfilling an individual medical prescription for a medicinal product specially produced for an individual patient.

(as amended by the decision of the Council of the Eurasian Economic Commission of 22.05.2023 N 60)

The production of such high-tech medicinal products is permitted by the authorized body of the Member State. Member States are obliged to ensure the equivalence of the requirements for the traceability of series and batches of medicinal products established by the legislation of the Member States and for pharmacovigilance in accordance with the acts of the Union bodies.

(as amended by the decision of the Council of the Eurasian Economic Commission dated 22.05.2023 N 60)

(clause 5.1 introduced by the decision of the Council of the Eurasian Economic Commission dated 17.03.2022